Renal cell cancer

• Health & Medicine

Kidney cancer drug gets initial ‘no’ for the NHS in England

A new kidney cancer drug combination of pembrolizumab with axitinib gets an initial no for the NHS in England A new kidney cancer drug combination of pembrolizumab with axitinib gets an initial no for the NHS in England

17 February 2020

• Health & Medicine

Kidney and lung cancer drugs approved on the NHS in Scotland

One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland. One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland.

12 June 2019

• Health & Medicine

Kidney cancer immunotherapy combo approved for NHS use in England

A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England. A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England.

5 April 2019

• Health & Medicine

Drug combination boosts kidney cancer survival in trials

Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials. Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials.

19 February 2019

Blocking cancer cell's energy generator could lead to new targeted treatments

CANCER RESEARCH UK scientists have found that blocking the pathway used by some kidney cancer cells to generate energy can kill the cancer cells, sparing the healthy ones. CANCER RESEARCH UK scientists have found that blocking the pathway used by some kidney cancer cells to generate energy can kill the cancer cells, sparing the healthy ones.

17 August 2011